Inside Our Impact Portfolio: Why We Invest in Dynavax Technologies
Here’s a look at why we added Dynavax to our Genus Fossil Free High-Impact Fund For the past several years, vaccines – and their makers – have dominated news headlines. Pharmaceutical company brand names have become as commonplace as the everyday brands we use at